Search research articles
Contact Us
Filters
Showing results (31-40 of 127) with videos related to
Page
of 13
Sort By:
Journal of Clinical Psychopharmacology
|
April 19, 2000
Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment
B G Pollock, F Laghrissi-Thode, W R Wagner
Journal of the National Cancer Institute
|
October 5, 1988
Regression models in clinical studies: determining relationships between predictors and response
F E Harrell, K L Lee, B G Pollock
Journal of Geriatric Psychiatry and Neurology
|
October 1, 1990
Pharmacodynamic issues relevant to geriatric psychopharmacology
B G Pollock, J M Perel, C F Reynolds
Psychopharmacology Bulletin
|
January 1, 1993
Nortriptyline in the hospitalized elderly: tolerance and side effect reduction
J Rosen, R Sweet, B G Pollock, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
May 23, 1997
Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detection
J P Foglia, D Sorisio, M Kirshner, et al.
Psychopharmacology Bulletin
|
January 1, 1996
Paroxetine is a novel nitric oxide synthase inhibitor
M S Finkel, F Laghrissi-Thode, B G Pollock, et al.
Journal of Geriatric Psychiatry and Neurology
|
July 1, 1994
Clomipramine in the elderly: tolerance and plasma levels
M E Kunik, B G Pollock, J M Perel, et al.
The Journal of Clinical Psychiatry
|
October 8, 1999
Continuation and maintenance pharmacotherapy in geriatric depression: an open-trial comparison of paroxetine and nortriptyline in patients older than 70 years
G Walters, C F Reynolds, B H Mulsant, et al.
Therapeutic Drug Monitoring
|
October 1, 1996
Bupropion plasma levels and CYP2D6 phenotype
B G Pollock, R A Sweet, M Kirshner, et al.
Clinical Pharmacology and Therapeutics
|
September 19, 2009
Predicting age-specific dosing of antipsychotics
H Uchida, B G Pollock, R R Bies, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 127) with videos related to
Sort By:
Page
of 13
Journal of Clinical Psychopharmacology
|
April 19, 2000
Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment
B G Pollock, F Laghrissi-Thode, W R Wagner
Journal of the National Cancer Institute
|
October 5, 1988
Regression models in clinical studies: determining relationships between predictors and response
F E Harrell, K L Lee, B G Pollock
Journal of Geriatric Psychiatry and Neurology
|
October 1, 1990
Pharmacodynamic issues relevant to geriatric psychopharmacology
B G Pollock, J M Perel, C F Reynolds
Psychopharmacology Bulletin
|
January 1, 1993
Nortriptyline in the hospitalized elderly: tolerance and side effect reduction
J Rosen, R Sweet, B G Pollock, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications
|
May 23, 1997
Quantitative determination of paroxetine in plasma by high-performance liquid chromatography and ultraviolet detection
J P Foglia, D Sorisio, M Kirshner, et al.
Psychopharmacology Bulletin
|
January 1, 1996
Paroxetine is a novel nitric oxide synthase inhibitor
M S Finkel, F Laghrissi-Thode, B G Pollock, et al.
Journal of Geriatric Psychiatry and Neurology
|
July 1, 1994
Clomipramine in the elderly: tolerance and plasma levels
M E Kunik, B G Pollock, J M Perel, et al.
The Journal of Clinical Psychiatry
|
October 8, 1999
Continuation and maintenance pharmacotherapy in geriatric depression: an open-trial comparison of paroxetine and nortriptyline in patients older than 70 years
G Walters, C F Reynolds, B H Mulsant, et al.
Therapeutic Drug Monitoring
|
October 1, 1996
Bupropion plasma levels and CYP2D6 phenotype
B G Pollock, R A Sweet, M Kirshner, et al.
Clinical Pharmacology and Therapeutics
|
September 19, 2009
Predicting age-specific dosing of antipsychotics
H Uchida, B G Pollock, R R Bies, et al.
Page
of 13